Pain Scientific Publications

Latest publication 02/05/2025

Characterization of a rat model of bortezomib-induced painful neuropathy

Background and Purpose Bortezomib (Velcade®) is a breakthrough treatment for multiple myeloma, significantly improving patient survival. However,...

Array
(
    [id_prestablog_news] => 456
    [id_shop] => 1
    [date] => 2025-02-05 20:03:33
    [date_modification] => 2026-05-22 09:00:54
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 
    [featured] => 0
    [ishero] => 0
    [prim_key] => 3676
    [id_lang] => 1
    [title] => Characterization of a rat model of bortezomib-induced painful neuropathy
    [paragraph] => Characterization of a rat model of bortezomib-induced painful neuropathy
    [content] => 
Authors
Natalie A Duggett, Sarah J L Flatters

Lab
Wolfson Centre for Age-Related Diseases, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Journal
British Journal of Pharmacology
Abstract
Background and Purpose 

Bortezomib (Velcade®) is a breakthrough treatment for multiple myeloma, significantly improving patient survival. However, its use is limited by painful neuropathy often resulting in dose reduction/cessation of first-line treatment due to lack of treatment. The aim of this study was to characterize a clinically relevant rat model of bortezomib-induced painful neuropathy, using established evoked measures and novel ethological techniques, to aid drug discovery. 

Experimental Approach 

Adult male Sprague–Dawley rats were injected i.p. with 0.1 and 0.2 mg·kg−1 bortezomib, or its vehicle, on days 0, 3, 7 and 10. Multiple behavioural approaches were utilized: mechanical hypersensitivity, cold allodynia, heat hypersensitivity, motor co-ordination, burrowing and voluntary wheel running. At maximal bortezomib-induced mechanical hypersensitivity, 200 mg·kg−1 ethosuximide/vehicle and 100 mg·kg−1 phenyl N-tert-butylnitrone (PBN)/vehicle were administered i.p. in separate experiments, and mechanical hypersensitivity assessed 1, 3 and 24 h later. 

Key Results 

Bortezomib induced dose-related mechanical hypersensitivity for up to 80 days. Bortezomib induced short-term cold allodynia, but no significant change in heat hypersensitivity, motor co-ordination, voluntary wheel running and burrowing behaviour compared to vehicle-treated controls. Systemic PBN and ethosuximide significantly ameliorated bortezomib-induced mechanical hypersensitivity. 

Conclusions and Implications 

These data characterize a reproducible rat model of clinical-grade bortezomib-induced neuropathy demonstrating long-lasting pain behaviours to evoked stimuli. Inhibition by ethosuximide and PBN suggests involvement of calcium and/or ROS in bortezomib-induced painful neuropathy. These drugs could be used as preclinical positive controls to assess novel analgesics. As ethosuximide is widely used clinically, translation to the clinic to treat bortezomib-induced painful neuropathy may be possible.
BIOSEB Instruments Used:
Basic spontaneous activity wheels (BIO-ACTIVW-M),Premium spontaneous activity wheels (BIO-ACTIWH2)

Keywords/Topics
Pain; Neuropathic pain
    [meta_description] => 
    [meta_keywords] => https://pmc.ncbi.nlm.nih.gov/articles/PMC5727311/

    [meta_title] => 
    [link_rewrite] => characterization-of-a-rat-model-of-bortezomib-induced-painful-neuropathy
    [actif_langue] => 1
    [read] => 784
    [count_comments] => 0
    [id] => 456
    [categories] => Array
        (
            [29] => Array
                (
                    [id_prestablog_categorie] => 29
                    [title] => Neuropathic pain
                    [link_rewrite] => Neuropathic-pain
                )

            [10] => Array
                (
                    [id_prestablog_categorie] => 10
                    [title] => Pain
                    [link_rewrite] => Pain
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => Characterization of a rat model of bortezomib-induced painful neuropathy
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [1875] => Array
                (
                    [name] => Basic spontaneous activity wheels
                    [description_short] => 
The BIOSEB Spontaneous Activity Wheel is an easy way to quantify rodent voluntary activity in their home cage environment. The embedded electronics perform a wide range of measurements, including: wheel revolutions, average/min/max speed, acceleration, utilization time, number of access events among others . A useful tool for studies on Drug Screening, Phenotyping Circadian Rhythms, and Neuromuscular Diseases; now with a software-independent LCD display and redesigned software controlling up to 64 wheels!

                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://bioseb.com/en/activity-motor-control-coordination/1875-spontaneous-activity-wheels.html
                )

        )

)
1